The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country.
Medicines have adverse reactions risks as well as efficacies benefits. It is important to minimize adverse reactions and maximize efficacy.
To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. This medicine selectively and competitively inhibits the activity of HMG-CoA reductase involving rosuvastatin calcium 20mg tablets 42 ea cholesterol rosuvastatin calcium 20mg in liver, thereby inhibiting cholesterol synthesis and then reducing cholesterol level rosuvastatin calcium 20mg tablets 42 ea blood.
It is usually used for the treatment of hypercholesterolemia or familial hypercholesterolemia. The most commonly reported adverse reactions include muscle pain, itch, rash and hives.
If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this click here and see rosuvastatin calcium 20mg tablets 42 ea doctor immediately.
The above symptoms do not describe all the adverse reactions to rosuvastatin calcium 20mg tablets 42 ea medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
DS Pharma Biomedical Co. Eli Lilly Japan K. K Elmed Eisai Co. Fuji Chemical Industry Co. Fuso Pharmaceutical Industries, Ltd.
Japan Bio Products Co. Kyowa Chemical Industry Co. Kyowa Hakko Tablets Co.
2018 ©